123I metaiodobenzylguanidine (MIBG) scintigraphy of retinoblastoma: preliminary experience.

123I metaiodobenzylguanidine (MIBG) is a radiopharmaceutical used for imaging neural crest tumours. The possibility of using 123I MIBG for imaging retinoblastomas has been assessed in this pilot study. Ten patients were studied, nine with clinically and histologically proved retinoblastomas and one...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bomanji, J, Hungerford, J L, Kingston, J E, Levison, D A, Britton, K E
Médium: Artigo
Jazyk:Inglês
Vydáno: 1989
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1041673/
https://ncbi.nlm.nih.gov/pubmed/2930761
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky